Onconic Therapeutics Inc. (KOSDAQ:476060)
24,750
+100 (0.41%)
Aug 14, 2025, 3:30 PM KST
Onconic Therapeutics Revenue
Onconic Therapeutics had revenue of 9.43B KRW in the quarter ending June 30, 2025, with 249.94% growth. This brings the company's revenue in the last twelve months to 29.43B, up 442.96% year-over-year. In the year 2024, Onconic Therapeutics had annual revenue of 14.84B, down -29.53%.
Revenue (ttm)
29.43B
Revenue Growth
+442.96%
P/S Ratio
9.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
272.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.84B | -6.22B | -29.53% |
Dec 31, 2023 | 21.06B | 20.96B | 22,064.25% |
Dec 31, 2022 | 95.00M | 35.00M | 58.33% |
Dec 31, 2021 | 60.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition